The US launches long-acting HIV prevention drug lenacapavir in Zimbabwe, aiming to support thousands of people.

Vulnerable young people, partners of drug users and victims of sexual violence also among those afflicted in world’s fastest growing HIV epidemic ...

Dar es Salaam. Tanzania has officially registered Lenacapavir, a long-acting injectable drug for the prevention and control of HIV, marking what officials describe as a significant milestone in the ...

Kenya has rolled out Lenacapavir, a long-acting injectable for HIV prevention, as the government steps up efforts to reduce new infections and strengthen the national HIV response.

Source: Over 270k Zimbabweans to benefit from new HIV drug – CITEZW The United States has launched lenacapavir (LEN), the new long-acting HIV prevention drug, in Zimbabwe, with plans to support ...

Lab technician Xolile Mhlanga works on lenacapavir at the Desmond Tutu Health Foundation's Masiphumelele Research Site, in Cape Town, South Africa, Tuesday, July 23, 2024.

The Standard In a landmark moment for Zimbabwe’s HIV response, the government officially launched lenacapavir (LEN)  in Epworth, a high-density suburb on the outskirts of Harare — deliberately taking ...

Dar es Salaam. Health practitioners in Tanzania are optimistic after the official registration of Lenacapavir, a long-acting ...

The border between The Gambia and Senegal is one of the most fluid in West Africa. Families live on both sides. Traders cross daily. Students commute. Religious leaders preach across territories. News ...

Development assistance for health has fallen back toward 2010 levels, disproportionately disrupting community-based HIV services and projecting increased infections and AIDS-related deaths.

The WHO said Denmark had met its required targets for elimination from 2021 to 2024. Read more at straitstimes.com. Read more ...